Pregnancy, Lactation, and Special Populations There are no human studies of BPC-157 in pregnant or nursing individuals, and it should be considered contraindicated in these populations given the lack of safety data
The results were striking: participants receiving the highest 12 mg dose achieved mean weight loss of approximately 24.2% of baseline body weight at week 48, compared to just 2.1% with placebo - representing an astounding 22 percentage point placebo-adjusted treatment effect
These are fundamentally different approaches to blood sugar management, with different side effect profiles, different effects on body weight, and different implications for long-term health
Cell 169 , 570586 (2017)
Based on an AtSOT1 structural model generated by alphafold, both cysteines are too far away for predicting any redox regulation mechanism involving an intramolecular disulfide
Dosage adjustment of thyroid hormone replacements is still an art since inappropriate dosing can result in symptoms of overtreatment or undertreatment with further complications including cardiovascular problems, loss of bone density, and neurological disturbances
